Debt-to-equity of Quoin Pharmaceuticals, Ltd. from 31 Mar 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Quoin Pharmaceuticals, Ltd. quarterly Debt-to-equity in % history and change rate from 31 Mar 2023 to 30 Sep 2025.
  • Quoin Pharmaceuticals, Ltd. Debt-to-equity for the quarter ending 30 Sep 2025 was 167%, a 78% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Quoin Pharmaceuticals, Ltd. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 167% +73% +78% 30 Sep 2025
Q2 2025 112% +18% +20% 30 Jun 2025
Q1 2025 93% +0.83% +0.9% 31 Mar 2025
Q4 2024 83% -5.4% -6.1% 31 Dec 2024
Q3 2024 94% +8.1% +9.4% 30 Sep 2024
Q2 2024 93% +13% +16% 30 Jun 2024
Q1 2024 92% -29% -24% 31 Mar 2024
Q4 2023 89% 31 Dec 2023
Q3 2023 86% 30 Sep 2023
Q2 2023 81% 30 Jun 2023
Q1 2023 121% 31 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.